Inhibitory effects of ginseng total saponins on behavioral sensitization and dopamine release induced by cocaine

Biological and Pharmaceutical Bulletin

Volumn 31, Issue 3, 2008, Pages 436-441

  Lee, BomBi ^a   Yang, Chae Ha ^b   Hahm, Dae Hyun ^c   Lee, Hye Jung ^c   Han, Seung Moo ^c   Kim, Kyung Soo ^d   Shim, Insop ^d  

^a BOSTON CHILDREN S HOSPITAL   (United States)

^b Daegu Haany University   (South Korea)

^c Kyung Hee University   (South Korea)

^d The Catholic University of Korea   (South Korea)

Author keywords

c Fos; Cocaine; Dopamine release; Ginseng total saponin; Locomotor activity

Indexed keywords

COCAINE; GINSENG EXTRACT;

ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BEHAVIOR CHANGE; DOPAMINE RELEASE; DRUG EFFECT; DRUG INHIBITION; GENE EXPRESSION; IMMUNOHISTOCHEMISTRY; IMMUNOREACTIVITY; IN VIVO STUDY; LOCOMOTION; MALE; NONHUMAN; ONCOGENE C FOS; RAT; SENSITIZATION;

ANIMALS; BEHAVIOR, ANIMAL; COCAINE; DOPAMINE; GENES, IMMEDIATE-EARLY; MALE; MICRODIALYSIS; MOTOR ACTIVITY; NUCLEUS ACCUMBENS; PANAX; PROTO-ONCOGENE PROTEINS C-FOS; RATS; RATS, SPRAGUE-DAWLEY; SAPONINS;

EID: 41149157396     PISSN: 09186158     EISSN: 13475215     Source Type: Journal    
DOI: 10.1248/bpb.31.436     Document Type: Article

References (51)

1. Richtard N. M., Woods S. C., Berger S. P., Strakowski S. M., Neurosci. Biobehav. Rev., 25, 427-443 (2001). Review.
2. Heidbreder C. A., Babovic-Vukcsanovic D., Shoaib M., Shippenberg T. S., J. Pharmacol. Exp. Ther., 275, 150-163 (1995).
3. Bradberry C. W., Roth R. H., Neurosci. Lett., 103, 97-102 (1989).
4. Steketee J. D., Brain Res. Brain Res. Rev., 41, 203-228 (2003). Review.
5. Fitzgerald L. W., Nestler E. J., "The Neurobiology of Cocaine," CRC Press, Boca Raton, FL, 1995, pp. 225-246.
6. Ritz M. C., Cone E. J., Kuhar M. J., Life. Sci., 46, 635-645 (1990).
7. Caine S. B., Negus S. S., Mello N. K., Patel S., Bristow L., Kulagowski J., Vallone D., Saiardi A., Borrelli E. J., Neuroscience, 22, 2977-2988 (2002).
8. Church W. H., Justice J. B., Jr., Byrd L. D., Eur. J. Pharmacol., 139, 345-348 (1987).
9. Izenwasser S., Werling L. L., Cox B. M., Brain Res., 520, 303-309 (1990).
10. Kalivas P. W., Duffy P., Synapse, 5, 48-58 (1990).
11. Spealman R. D., Psychopharmacology (Berl), 101, 142-145 (1990).
12. Weissenborn R., Deroche V., Koob G. F., Weiss F., Psychopharmacology (Berl), 126, 311-322 (1966).
13. Crombag H. S., Jedynak J. P., Redmond K., Robinson T. E., Hope B. T., Behav. Brain Res., 136, 455-462 (2002).
14. Curran E. J., Akil H., Watson S. J., Neurochem. Res., 21, 1425-1435 (1996).
15. Nabata H., Saito H., Takagi K., Jpn. J. Pharmacol., 23, 29-41 (1973).
16. Kim H. S., Kang J. G., Seong Y. H., Nam K. Y., Oh K. W., Pharmacol., Biochem. Behav., 50, 23-27 (1995).
17. Tsang D., Yeung H. W., Tso W. W., Peck H., Planta Med., 3, 221-224 (1985).
18. Kim H. S., Kang J. G., Oh K. W., Gen. Pharmacol., 26, 1071-1076 (1995).
19. Kim H. S., Kang J. G., Rheu H. M., Cho D. H., Oh K. W., Planta Med., 61, 22-25 (1995).
20. Kim H. S., Kim K. S., Behav. Brain Res., 103, 55-61 (1999).
21. Kim S. E., Shim I., Chung J. K., Lee M. C., Neuropsychopharmacology, 31, 1714-1721 (2006).
22. Ko S. R., Kim S. C., Choi K. J., Kor. J. Pharmacogn., 23, 24-28 (1992).
23. Ando K., Cho S. I., Kitagawa I., Nishiyama N., Saito H., Brain Res., 649, 7-11 (1994).
24. Chae Y., Yang C. H., Kwon Y. K., Kim M. R., Pyun K. H., Hahm D. H., Lee H. J., Shim I., Neurosci. Lett., 358, 87-90 (2004).
25. Paxinos G., Watson C., "The Rat Brain in Stereotaxic Coordinates," Academic Press, New York, 1986.
26. Olive M. F., Mehmert K. K., Hodge C. W., Brain Res. Protoc., 5, 16-24 (2000).
27. Akimoto K., Kamanura T., Otsuki S., Brain Res., 490, 339-344 (1989).
28. Friedman E., Gershom S., Rotrosen J., Br. J. Pharmacol., 54, 61-64 (1975).
29. Hadfield M. G., Mott D. E. W., Ismay J. A., Biochem. Pharmacol., 29, 1861-1863 (1980).
30. Dwoskin L. P., Peris J., Yasuda R. P., Philpott K., Zahnster N. R., Life Sci., 42, 255-262 (1988).
31. Meno M., Pradhan S., Hanbauer I., Neuropharmacology, 20, 1145-1150 (1981).
32. Taylor D., Ho B. T., Fager J. D., Commun. Psychol. Pharmacol., 3, 137-142 (1979).
33. Uslaner J., Badiani A., Norton C. S., Day H. E., Watson S. J., Akil H., Robinson T. E., Eur. J. Neurosci., 13, 1977-1983 (2001).
34. Pecins-Thompson M., Peris J., Psychopharmacology (Berl), 110, 443-450 (1993).
35. Shim I., Javaid J. I., Wirtshafter D., Jang S. Y., Shin K. H., Lee H. J., Chung Y. C., Chun B. G., Behav. Brain Res., 121, 137-147 (2001).
36. Tokuyama S., Oh K. W., Kim H. S., Takahashi M., Kaneto H., Jpn. J. Pharmacol., 59, 423-425 (1992).
37. Kim H. S., Jang C. G., Oh K. W., Seong Y. H., Rheu H. M., Cho D. H., Kang S. Y., Pharmacol. Biochem. Behav., 53, 185-190 (1996).
38. Kim H. S., Shin E. J., Jang C. G., Lee M. K., Eun J. S., Hong J. T., Oh K. W., Arch. Pharm. Res., 28, 995-1001 (2005).
39. Kim H. S., Jang C. G., Lee M. K., Planta Med., 56, 158-163 (1990).
40. Kim H. S., Oh K. W., Park W. K., Choi J. W., Bae D. S., Arch. Pharm. Res., 10, 188-192 (1987).
41. Suh H. W., Song D. K., Kim S. Y., Gen. Pharmac., 29, 873-877 (1997).
42. Kim H. S., Jang C. G., Oh K. W., Oh S., Rheu H. M., Rhee G. S., Seong Y. H., Park W. K., J. Ethnopharmacol., 60, 33-42 (1998).
43. Kim Y. C., Lee J. H., Kim M. S., Lee N. G., Arch. Pharm. Res., 8, 45-49 (1985).
44. Wu C. F., Liu Y. L., Song M., Pharmacol. Biochem. Behav., 76, 103-109 (2003).
45. Chiara G. D., Drug Alcohol Depend., 38, 95-137 (1995).
46. Heimer L., Zahm D. S., Churchill L., Kalivas P. W., Wohltman C., Neuroscience, 41, 89-125 (1991).
47. Cousins M. S., Roberts D. C., Wit H. D., Drug Alcohol Depend., 65, 209-220 (2002).
48. Cadoni C., Chiara G. D., Neuroscience, 90, 447-455 (1999).
49. Takahashi E., Kudo K., Harada K., Kashimoto T., Miyate Y., Kakizaki A., Takahashi E., Eur. J. Pharmacol., 369, 23-32 (1999).
50. Tachikawa E., Kudo K., Nunokawa M., Kashimoto T., Takahashi E., Kitagawa S., Biochem. Pharmacol., 62, 943-951 (2001).
51. Kim H. S., Kim K. S., Oh K. W., Pharmacol. Biochem. Behav., 63, 407-412 (1999).